Dr. Hamelin is currently the Director, Research and Development for Western Canada with Pfizer Canada Inc. In this role, Bettina leads the development and implementation of the R&D partnership strategy for Pfizer in Western Canada including investigator initiated preclinical and clinical research efforts across 5 therapeutic areas.
Prior to joining Pfizer, Bettina was tenured professor at the Faculty of Pharmacy at Laval University in Quebec City, where she ran a well-funded research program on the pharmacokinetics and pharmacogenetics of cardiovascular drugs, and cardiovascular disease risk factors and treatment in women.
From 1999 until 2004, she held senior research positions at Biochem Pharma, where most recently she was Director of Drug Metabolism and Pharmacokinetics.
Bettina pursued a Bachelor of Science in Chemistry and a Bachelor of Science in Pharmacy in Germany as well as in the US and also holds a Doctor of Pharmacy degree from the University of Kentucky. During her scientific career, Bettina has published over 35 publications, over 85 abstracts and 2 patents. She has been actively involved in many professional associations and served as the President of the Canadian College of Clinical Pharmacy. She joined Pfizer in 2004 as a cardiovascular Regional Medical and Research Specialist with the responsibility of developing relationships and key strategic partnerships with the biomedical and research community in Quebec and the Atlantic provinces.
Bettina relocated to Vancouver in 2007 with her husband Richard and her boys, Christian and David. Bettina enjoys playing the violin and the piano, and she is an avid outdoors enthusiast alongside her husband and sons.
